NTY Nbty Inc.

Get Your Sales in Shape With the Power of the MET-Rx(R) Brand Name BOHEMIA, N.Y., Feb. 24 /PRNewswire-FirstCall/ -- NBTY, Inc. (http://www.nbty.com/). MET-Rx, the premier brand name in sports nutrition, and the one that fitness-minded consumers look to for cutting-edge protein & low-carb bars, sports supplements & drinks, announces its new strategic licensing division -- MET-Rx Branding. As the leader in the sports nutrition industry -- MET-Rx is now leveraging its brand strength into new product and service categories. A MET-Rx license offers great sales potential for you, as more and more consumers rely on our trusted name for their fitness and nutritional needs. What's more, the MET-Rx brand is supported by a multi-million dollar marketing effort ranging from high profile television sponsorships, including the MET-Rx World's Strongest Man to high impact national advertising across all mediums. MET-Rx also builds appeal with its contingent of over 50 top athlete endorsers, including Davana Medina -- 2003 IFBB Figure Olympia Champion, Bill Kazmaier -- 3 time MET-Rx World's Strongest Man champion, Susie Curry -- 4 time Ms. Fitness Olympia, as well as fitness expert Frank Sepe, author of the "Truth" and a regular on the ESPN show Cold Pizza. With licensed products exceeding $75 billion dollars in U.S. retail sales in 2002, including $10 billion in sports related products, the MET-Rx name, with its built in audience, is perfect for branding apparel, sporting goods and almost any type of accessory. Put the power of the MET-Rx brand to work for you. Contact Darren Schneider at MET-RX Branding, 1-800-645-5412, or at the MAGIC Marketplace, Las Vegas NV, February 23-26, 2004, MET-RX Branding Booth # AL 14004. MET-Rx Branding. Where your profits will be Bigger. Better. Stronger. ABOUT NBTY NBTY is a leading vertically integrated manufacturer and distributor of a broad line of high-quality, value-priced nutritional supplements in the United States and throughout the world. The Company markets approximately 1,500 products under several brands, including Nature's Bounty(R), Vitamin World(R), Puritan's Pride(R), Holland & Barrett(R), Rexall(R), Sundown(R), MET-Rx(R), WORLDWIDE Sport Nutrition(R), American Health(R), GNC (UK)(R) and DeTuinen(R). This release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to our financial condition, results of operations and business. All of these forward-looking statements, which can be identified by the use of terminology such as "subject to," "believe," "expects," "may," "will," "should," "can," or "anticipates," or the negative thereof, or variations thereon, or comparable terminology, or by discussions of strategy which, although believed to be reasonable, are inherently uncertain. Factors which may materially affect such forward-looking statements include: (i) slow or negative growth in the nutritional supplement industry; (ii) interruption of business ornegative impact on sales and earnings due to acts of war, terrorism, bio-terrorism, civil unrest or disruption of mail service; (iii) adverse publicity regarding nutritional supplements; (iv) inability to retain customers of companies (or mailing lists) recently acquired; (v) increased competition; (vi) increased costs; (vii) loss or retirement of key members of management; (viii) increases in the cost of borrowings and unavailability of additional debt or equity capital; (ix) unavailability of, or inability to consummate, advantageous acquisitions in the future, including those that may be subject to bankruptcy approval or the inability of NBTY to integrate acquisitions into the mainstream of its business; (x) changes in general worldwide economicand political conditions in the markets in which NBTY may compete from time to time; (xi) the inability of NBTY to gain and/or hold market share of its wholesale and/or retail customers anywhere in the world; (xii) unavailability of electricity in certain geographical areas; (xiii) the inability of NBTY to obtain and/or renew insurance; (xiv) exposure to and expense of defending and resolving, product liability claims and other litigation; (xv) the ability of NBTY to successfully implement its business strategy; (xvi) the inability of NBTY to manage its retail, wholesale, manufacturing and other operations efficiently; (xvii) consumer acceptance of NBTY's products; (xviii) the inability of NBTY to renew leases on its retail locations; (xix) inability of NBTY's retail stores to attain or maintain profitability; (xx) the absence of clinical trials for many of NBTY's products; (xxi) sales and earnings volatility and/or trends; (xxii) the efficacy of NBTY's Internet and on-line sales and marketing; (xxiii) fluctuations in foreign currencies, including the British Pound; (xxiv) import-export controls on sales to foreign countries; (xxv) the inability of NBTY to secure favorable new sites for, and delays in opening, new retail locations; (xxvi) introduction of new federal, state, local or foreign legislation or regulation or adverse determinations by regulators anywhere in the world (including the banning of products) and more particularly the Food Supplements Directive and the Traditional Herbal Medicinal Products Directive in Europe; (xxvii) the mix of NBTY's products and the profit margins thereon; (xxviii) the availability and pricing of raw materials; (xxix) risk factors discussed in NBTY's filings with the U.S. Securities and Exchange Commission; and (xxx) other factors beyond NBTY's control. Readers are cautioned not to place undue reliance on forward-looking statements. NBTY cannot guarantee future results, trends, events, levels of activity, performance or achievements. NBTY does not undertake and specifically declines any obligation to update, republish or revise forward- looking statements to reflect events or circumstances after the date hereof or to reflect the occurrences of unanticipated events. DATASOURCE: NBTY, Inc. CONTACT: Harvey Kamil, President and CFO of NBTY, Inc., +1-631-244-2020; or Carl Hymans of G.S. Schwartz & Co., +1-212-725-4500, , for NBTY, Inc. Web site: http://www.nbty.com/

Copyright